Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87.4M
Number of holders
36
Total 13F shares, excl. options
23.3M
Shares change
+1.44M
Total reported value, excl. options
$108M
Value change
+$6.61M
Number of buys
26
Number of sells
-9
Price
$4.63

Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q3 2022

39 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 23.3M shares of 87.4M outstanding shares and own 26.66% of the company stock.
Largest 10 shareholders include FMR LLC (12M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), VANGUARD GROUP INC (1.86M shares), Redmile Group, LLC (1.58M shares), BlackRock Inc. (1.53M shares), Velan Capital Investment Management LP (549K shares), GEODE CAPITAL MANAGEMENT, LLC (521K shares), Triatomic Management LP (366K shares), Saba Capital Management, L.P. (348K shares), and STATE STREET CORP (288K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.